← Back to Clinical Trials
Recruiting NCT07182396

NCT07182396 Effects of Video Games and Ball Tossing on Eye Hand Coordination in Elderly With Mild Cognitive Impairment.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07182396
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Cognitive Dysfunction
Study Type INTERVENTIONAL
Enrollment 34 participants
Start Date 2024-09-13
Primary Completion 2025-12-10

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Experimental GroupControl Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 34 participants in total. It began in 2024-09-13 with a primary completion date of 2025-12-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

One of the key challenges faced by individuals with mild cognitive impairment (MCI) is the decline in cognitive and motor abilities, particularly eye-hand coordination (EHC), which is essential for performing daily activities and maintaining independence. Impaired EHC can severely affect the quality of life in older adults, leading to difficulties in performing routine tasks like dressing, eating, and bathing, and increasing dependency on caregivers. Signs and symptoms include difficulty with precise movements like buttoning clothes, spilling drinks while pouring, struggling to catch a ball, messy handwriting. This study aims to explore and compare the effectiveness of two interventions-video games and ball tossing exercises-in improving Eye-hand coordination (EHC) in older adults with Mild Cognitive Impairment (MCI). Key outcome measures, including the Beery-Buktenica Developmental Test of Visual-Motor Integration (Beery VMI) and its supplemental test visual perception test and motor coordination test, will evaluate the effectiveness of the interventions on eye hand coordination. We will include older adults with 60 and above age with MoCA score of 18-25(MCI patients), who can do independent ADLs and beery vmi score of 80 and above. The participants would be assessed at the start of intervention through MoCA scale for MCI screening and Beery VMI testing method for Eye Hand Coordination for inclusion score.

Eligibility Criteria

Inclusion Criteria: * Older population aged from 60years and above * Normal/ normal to corrected vision * MoCA Score of 18-25 for screening / MCI patients * Can do Independent ADLS * Beery VMI Score: 80 and above score Exclusion Criteria: * History of head trauma, loss of consciousness, stroke, rapid cognitive decline * Diagnosis of mental illness/neurocognitive disorders * Diagnosed Vestibular disorders * Hearing, vision and communication impairments

Contact & Investigator

Central Contact

Muttayaba Ishtiaq, DPT

✉ imuttayaba58@gmail.com

📞 +92 321-5312943

Frequently Asked Questions

Who can join the NCT07182396 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Cognitive Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07182396 currently recruiting?

Yes, NCT07182396 is actively recruiting participants. Contact the research team at imuttayaba58@gmail.com for enrollment information.

Where is the NCT07182396 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07182396 clinical trial?

NCT07182396 is sponsored by Foundation University Islamabad. The trial plans to enroll 34 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology